CLOCK and cancer: Age prediction models using methylation at CpGs (i.e., epigenetic clock or biological aging) have been shown to predict aging-related outcomes, such as all-cause mortality [43], cognitive and physical functions [42], Down syndrome [74], and cancers of the lung, breast, kidney, and blood [75].